Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 14, Issue 1, Pages 29
Publisher
MDPI AG
Online
2020-12-31
DOI
10.3390/ph14010029
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amyotrophic lateral sclerosis: a clinical review
- (2020) P. Masrori et al. EUROPEAN JOURNAL OF NEUROLOGY
- The Beginning of Genomic Therapies for ALS
- (2020) Orla Hardiman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk factors for amyotrophic lateral sclerosis: A regional United States case‐control study
- (2020) Angeline S. Andrew et al. MUSCLE & NERVE
- Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis
- (2019) Natalia Nowicka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epidemiology of amyotrophic lateral sclerosis
- (2019) Elisa Longinetti et al. CURRENT OPINION IN NEUROLOGY
- Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials
- (2019) Stephen A. Goutman et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Lou Gehrig’s Disease (ALS): UBQLN2 Mutations Strike Out of Phase
- (2019) Nicole Higgins et al. STRUCTURE
- Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial
- (2019) Jesus S. Mora et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients
- (2019) Jin-Mo Park et al. NEUROLOGICAL SCIENCES
- Protective effect of edaravone on blood-brain barrier by affecting NRF-2/HO-1 signaling pathway
- (2019) Jing Liu et al. Experimental and Therapeutic Medicine
- Long‐term edaravone efficacy in amyotrophic lateral sclerosis: Post‐hoc analyses of Study 19 (MCI186‐19)
- (2019) Jeremy Shefner et al. MUSCLE & NERVE
- Edaravone attenuates experimental asthma in mice through induction of HO‑1 and the Keap1/Nrf2 pathway
- (2019) Yuting Pan et al. Experimental and Therapeutic Medicine
- How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?
- (2018) Kazutoshi Watanabe et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Neuroprotection of edaravone on the hippocampus of kainate-induced epilepsy rats through Nrf2/HO-1 pathway
- (2018) Zhiguang Liu et al. NEUROCHEMISTRY INTERNATIONAL
- Edaravone Improves Septic Cardiac Function by Inducing an HIF-1α/HO-1 Pathway
- (2018) Chao He et al. Oxidative Medicine and Cellular Longevity
- Prevalence of Amyotrophic Lateral Sclerosis — United States, 2014
- (2018) Paul Mehta et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs
- (2018) Manoj Kumar Jaiswal MEDICINAL RESEARCH REVIEWS
- Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling
- (2017) Yoon Oh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- (2017) Koji Abe et al. LANCET NEUROLOGY
- Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis
- (2017) Ming-Dong Wang et al. NEUROTOXICOLOGY
- Post-hoc analysis of MCI186-17, the extension study to MCI186-16, the confirmatory double-blind, parallel-group, placebo-controlled study of edaravone in amyotrophic lateral sclerosis
- (2017) Fumihiro Takahashi et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Amyotrophic lateral sclerosis
- (2017) Orla Hardiman et al. Nature Reviews Disease Primers
- Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS)
- (2016) Leslie I. Grad et al. Cold Spring Harbor Perspectives in Medicine
- Evaluation of edaravone against radiation-induced oral mucositis in mice
- (2015) Noriko Nakajima et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Edaravone leads to proteome changes indicative of neuronal cell protection in response to oxidative stress
- (2015) Mohammad-Saeid Jami et al. NEUROCHEMISTRY INTERNATIONAL
- Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants
- (2015) Shahram Saberi et al. NEUROLOGIC CLINICS
- Edaravone, a Free Radical Scavenger, Delayed Symptomatic and Pathological Progression of Motor Neuron Disease in the Wobbler Mouse
- (2015) Ken Ikeda et al. PLoS One
- Exposure to Environmental Toxicants and Pathogenesis of Amyotrophic Lateral Sclerosis: State of the Art and Research Perspectives
- (2013) Francesca Trojsi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neuroprotective effects of edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats
- (2013) Shanshan Zhou et al. NEUROTOXICOLOGY
- Amyotrophic lateral sclerosis
- (2011) Matthew C Kiernan et al. LANCET
- Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
- (2011) Nian Xiong et al. PLoS One
- Review of the Use of the Glutamate Antagonist Riluzole in Psychiatric Disorders and a Description of Recent Use in Childhood Obsessive-Compulsive Disorder
- (2010) Paul Grant et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons
- (2008) Wen Ji Yuan et al. BMC NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started